文献速递心力衰竭与心肌病心律失常

儿童肥厚型心肌病心脏性猝死风险预测模型:验证研究

A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy.
PubMed 文献 · Circulation · 2020-05-18

研究在572例18岁前诊断的孤立性肥厚型心肌病患者中,构建并外部验证了预测5年心脏性猝死复合事件的竞争风险模型。临床模型和临床/遗传模型c-statistic分别为0.75和0.76,外部验证为0.71和0.72。模型纳入儿童特有风险因素,可用于个体化风险预测。

要点

  • 儿童肥厚型心肌病5年SCD事件累积比例为9.1%。
  • 风险预测因素包括诊断年龄、NSVT、不明原因晕厥、室间隔/左室后壁/左房直径z评分、LVOT峰值压差和致病性变异。
  • LVOT压差呈反向关联,SCD家族史无关联,与成人不同。

核心结论

  • 研究提供了一个验证的SCD风险预测模型,预测准确率>70%,纳入儿童肥厚型心肌病特有风险因素,可个体化预测5年SCD事件风险。

研究设计与样本

  • 国际多中心观察性队列研究,纳入诊断时<18岁的孤立性肥厚型心肌病患者,主要终点为诊断至5年随访SCD复合事件(SCD、复苏性心脏骤停、适当ICD电击终止的SCD),采用竞争风险模型(cause-specific hazard回归)并boosted、10次重复4折交叉验证调参,外部验证队列为SHaRe(n=285)。

主要发现

  • 整体572例患者,2855患者年随访,5年SCD事件累积比例为9.1%(14例SCD、25例复苏性心脏骤停、14例ICD适当电击终止的SCD)。
  • 风险预测因素包括诊断年龄、记录到的非持续性室性心动过速、不明原因晕厥、室间隔直径z评分、左室后壁直径z评分、左房直径z评分、左室流出道峰值压差和致病性变异的存在。
  • 与成人不同,左室流出道压差呈反向关联,SCD家族史与SCD无关联。
  • 临床模型和临床/遗传模型c-statistic分别为0.75和0.76,外部验证c-statistic分别为0.71和0.72。

关键数值与推荐

  • 5年SCD事件累积比例为9.1%。
  • 临床模型c-statistic为0.75,临床/遗传模型为0.76。
  • 外部验证c-statistic分别为0.71和0.72。
  • 预测准确率>70%。

临床怎么用

  • 该模型可用于儿童肥厚型心肌病患者的个体化SCD风险预测,辅助临床实践指南应用和ICD植入的共享决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertrophic cardiomyopathy is the leading cause of sudden cardiac death (SCD) in children and young adults. Our objective was to develop and validate a SCD risk prediction model in pediatric hypertrophic cardiomyopathy to guide SCD prevention strategies. METHODS: In an international multicenter observational cohort study, phenotype-positive patients with isolated hypertrophic cardiomyopathy <18 years of age at diagnosis were eligible. The primary outcome variable was the time from diagnosis to a composite of SCD events at 5-year follow-up: SCD, resuscitated sudden cardiac arrest, and aborted SCD, that is, appropriate shock following primary prevention implantable cardioverter defibrillators. Competing risk models with cause-specific hazard regression were used to identify and quantify clinical and genetic factors associated with SCD. The cause-specific regression model was implemented using boosting, and tuned with 10 repeated 4-fold cross-validations. The final model was fitted using all data with the tuned hyperparameter value that maximizes the c-statistic, and its performance was characterized by using the c-statistic for competing risk models. The final model was validated in an independent external cohort (SHaRe [Sarcomeric Human Cardiomyopathy Registry], n=285). RESULTS: Overall, 572 patients met eligibility criteria with 2855 patient-years of follow-up. The 5-year cumulative proportion of SCD events was 9.1% (14 SCD, 25 resuscitated sudden cardiac arrests, and 14 aborted SCD). Risk predictors included age at diagnosis, documented nonsustained ventricular tachycardia, unexplained syncope, septal diameter z-score, left ventricular posterior wall diameter z score, left atrial diameter z score, peak left ventricular outflow tract gradient, and presence of a pathogenic variant. Unlike in adults, left ventricular outflow tract gradient had an inverse association, and family history of SCD had no association with SCD. Clinical and clinical/genetic models were developed to predict 5-year freedom from SCD. Both models adequately discriminated between patients with and without SCD events with a c-statistic of 0.75 and 0.76, respectively, and demonstrated good agreement between predicted and observed events in the primary and validation cohorts (validation c-statistic 0.71 and 0.72, respectively). CONCLUSION: Our study provides a validated SCD risk prediction model with >70% prediction accuracy and incorporates risk factors that are unique to pediatric hypertrophic cardiomyopathy. An individualized risk prediction model has the potential to improve the application of clinical practice guidelines and shared decision making for implantable cardioverter defibrillator insertion. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT0403679.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Miron A, Lafreniere-Roula M, Steve Fan CP, et al. A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy. Circulation. 2020. PMID: 32418493. doi:10.1161/CIRCULATIONAHA.120.047235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。